COMP <GO>
AVR vs ZJYL // ALTMAN Z-SCORE & DEBT/EQUITY
Anteris Technologies Global Corp. (NASDAQ) VS. JIN MEDICAL INTERNATIONAL LTD. (Class A) (NASDAQ) • 15-METRIC TALLY: AVR 2
— ZJYL 6
■ METRIC PARITY
LAST: $6.42 (+5.25%) • MKT CAP: $625.9M
balance-sheet
—
LAST: $1.86 (-2.10%) • MKT CAP: $294.2M
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVR VS. ZJYL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVR | ZJYL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.30% | 29.20% | +41.10 | AVR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 47.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.74% | -1.27% | -11.47 | ZJYL | /fcf-yield <GO> |
| Operating Margin | -60.00% | 2.90% | -62.90 | ZJYL | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 5.80% | -65.80 | ZJYL | /net-margins <GO> |
| Revenue Growth (YoY) | -29.20% | -12.00% | -17.20 | ZJYL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | ZJYL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.3 | 61.0 | -19.66 | ZJYL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $625.9M | $294.2M | $331.7M | AVR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVR REV | ZJYL REV | AVR GROSS % | ZJYL GROSS % | AVR FCF | ZJYL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.9M | $20.7M | 70.3% | 29.2% | -$79.8M | -$3.7M |
| FY 2024 | $2.7M | $23.5M | 46.8% | 40.4% | -$63.5M | -$1.4M |
| FY 2023 | — | $19.8M | — | — | — | $3.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVR // BETA —
ZJYL // BETA —